# By Developing a Radiomics Model to Predict the Prognosis of Patients With Hepatocellular Carcinoma After Microwave Ablation

> **NCT03880721** · — · UNKNOWN · sponsor: **Chinese PLA General Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **PROCEDURE:** Microwave abaltion

## Key facts

- **NCT ID:** NCT03880721
- **Lead sponsor:** Chinese PLA General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01-01
- **Primary completion:** 2020-08
- **Final completion:** 2021-04
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2019-05-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03880721

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03880721, "By Developing a Radiomics Model to Predict the Prognosis of Patients With Hepatocellular Carcinoma After Microwave Ablation". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03880721. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*